Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor β
Open Access
- 25 July 2006
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (8) , 2616-2625
Abstract
Objective: Allograft inflammatory factor 1 (AIF‐1), a protein initially identified in chronically rejected rat cardiac allografts, is involved in the immune response and proliferative vasculopathy that occurs during allograft rejection. Three well‐characterized isoforms of AIF‐1 result from alternative messenger RNA (mRNA) splicing. We previously identified a strong association of systemic sclerosis (SSc) with a polymorphism in AIF‐1 isoform 2. The purpose of this study was to investigate AIF‐1 expression in affected tissues from patients with SSc and to examine the regulation of its isoforms by transforming growth factor β (TGFβ).Methods: AIF‐1 in the skin and lung tissues of patients with SSc was analyzed by immunochemistry. AIF‐1 isoform expression in response to TGFβ and interferon‐γ stimulation was examined by quantitative polymerase chain reaction (PCR).Results: AIF‐1 protein was present in affected vessels of the lung and skin lesions of patients with SSc. Quantitative PCR showed an average of 14‐fold higher mRNA levels in affected SSc skin than in normal skin. Double‐label immunofluorescence staining demonstrated that T cells, macrophages, and endothelial cells in affected tissues expressed AIF‐1. Stimulation of peripheral blood mononuclear cells with TGFβ caused a specific and significant increase in the expression of AIF‐1 isoform 2 transcripts (P < 0.005), which was due to stabilization of AIF‐1 isoform 2 mRNA.Conclusion: These data suggest that AIF‐1 plays an important role in the pathogenesis of SSc owing to its increased expression in affected tissues and to the specific stimulation of AIF‐1 isoform 2 by TGFβ.Keywords
This publication has 32 references indexed in Scilit:
- The ability of AIF-1 to activate human vascular smooth muscle cells is lost by mutations in the EF-hand calcium-binding regionExperimental Cell Research, 2005
- Over-Expression of AIF-1 in Liver Allografts and Peripheral Blood Correlates with Acute Rejection after Transplantation in RatsAmerican Journal of Transplantation, 2004
- Transcriptional Inhibition of Type I Collagen Gene Expression in Scleroderma Fibroblasts by the Antineoplastic Drug Ecteinascidin 743Journal of Biological Chemistry, 2003
- p38 Mitogen-activated Protein Kinase Stabilizes mRNAs That Contain Cyclooxygenase-2 and Tumor Necrosis Factor AU-rich Elements by Inhibiting DeadenylationJournal of Biological Chemistry, 2003
- Posttranscriptional regulation of (TGF- -stimulated clone-22) gene by TGF- 1Biochemical and Biophysical Research Communications, 2003
- AIF-1 Is an Actin-Polymerizing and Rac1-Activating Protein That Promotes Vascular Smooth Muscle Cell MigrationCirculation Research, 2003
- Macrophage-restricted and Interferon γ-inducible Expression of the Allograft Inflammatory Factor-1 Gene Requires Pu.1Journal of Biological Chemistry, 2002
- IRT-1, a Novel Interferon-γ-responsive Transcript Encoding a Growth-suppressing Basic Leucine Zipper ProteinJournal of Biological Chemistry, 1998
- cDNA Cloning of Human Allograft Inflammatory Factor-1: Tissue Distribution, Cytokine Induction, and mRNA Expression in Injured Rat Carotid ArteriesBiochemical and Biophysical Research Communications, 1996
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980